Cephalon, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Document Sample
Cephalon, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report Powered By Docstoc
					Cephalon, Inc.

_________________________________________________________________________________



Cephalon, Inc.                                                                Company Overview

Fast Facts                                                                    Cephalon,        Inc.   (Cephalon),     is    a
                                      41 Moores Road, Frazer, 19355, United
                                                                              biopharmaceutical company that specializes in
Headquarters Address                                                          the research, development and marketing of
                                      States of America
                                                                              innovative therapeutic products. The company
Telephone                             + 1 610 3440200                         develops products for the treatment of cancer,
                                                                              pain, central nervous system (CNS), and
Fax                                   + 1 610 3440065
                                                                              inflammatory disease. Its product portfolio
                                                                              includes modafinil tablets, fentanyl buccal
Website                               www.cephalon.com
                                                                              tablets, arsenic trioxide injections, tiagabine
                                                                              hydrochloride , modafinil , oral transmucosal
Ticker Symbol, Stock Exchange         N/A
                                                                              fentanyl     citrate   and      cyclobenzaprine
Number of Employees                   N/A
                                                                              hydrochloride extended release capsules.
                                                                              Cephalon has operations in the US, Europe, the
Fiscal Year End                       December                                Middle East and Africa and offers more than 150
                                                                              branded and generic products in 100 countries.
Revenue (in US$ million)              N/A                                     Cephalon      is     a  subsidiary   of    Teva
                                                                              Pharmaceutical Industries Ltd. Cephalon is
                                                                              headquartered in Frazer, Pennsylvania, the US.

                                                                              Key Competitors
SWOT Analysis                                                                 GlaxoSmithKline plc (Ticker: GSK)

Strengths                             Weaknesses                              Jazz Pharmaceuticals, Inc.

Backing of parent company             Product recalls                         Johnson & Johnson (Ticker: JNJ)

Focused on research and development                                           Purdue Pharma L.P.
activities
                                                                              Roche Laboratories Inc.
Global presence

Opportunities                         Threats

Growing prevalence of cancer          Intense competition

Growing prevalence of CNS disorders Rising labor costs in the US

Positive outlook for the global       Tightening of the FDA’s regulatory
pharmaceutical industry               oversight




___________________________________________________________________________________________

Cephalon, Inc. - SWOT Profile                                                                                     Page 1
Cephalon, Inc.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 4
    1.1      Company Overview ................................................................................................................................................4
    1.2      Business Description ..............................................................................................................................................4
    1.3      Major Products and Services .................................................................................................................................5
2     SWOT Analysis ........................................................................................................................................ 6
    2.1      SWOT Analysis - Overview ....................................................................................................................................6
    2.2      Strengths ................................................................................................................................................................6
    2.3      Weaknesses ...........................................................................................................................................................6
    2.4      Opportunities ..........................................................................................................................................................6
    2.5      Threats ...................................................................................................................................................................7
3     History ...................................................................................................................................................... 8
4     Locations and Subsidiaries .................................................................................................................. 10
    4.1      Head Office ..........................................................................................................................................................10
    4.2      Other Locations and Subsidiaries ........................................................................................................................10
5     Appendix ................................................................................................................................................ 12
    5.1      Methodology .........................................................................................................................................................12
    5.2      Disclaimer.............................................................................................................................................................12




___________________________________________________________________________________________

Cephalon, Inc. - SWOT Profile                                                                                                                                               Page 2
Cephalon, Inc.

__________________________________________________________________________________________



List of Tables

Table 1: Major Products and Services ..................................................................................................................................5
Table 2: History.......................................................................................................................................................................8
Table 3: Subsidiaries ............................................................................................................................................................10




___________________________________________________________________________________________

Cephalon, Inc. - SWOT Profile                                                                                                                                              Page 3
Cephalon, Inc.

_________
				
DOCUMENT INFO
Description: Synopsis ICD Research's "Cephalon, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Cephalon, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Cephalon, Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • The profile also contains information on business operations, company history, major products and services, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Cephalon, Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Cephalon, Inc. (Cephalon), is a biopharmaceutical company that specializes in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of cancer, pain, central nervous system (CNS), and inflammatory disease. Its product portfolio includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, tiagabine hydrochloride , mo
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.